M&A Deal Summary

Aclaris Acquires Confluence Life Sciences

On August 8, 2017, Aclaris acquired life science company Confluence Life Sciences for 10M USD

Acquisition Highlights
  • This is Aclaris’ 2nd transaction in the Life Science sector.
  • This is Aclaris’ largest (disclosed) transaction.
  • This is Aclaris’ 2nd transaction in the United States.
  • This is Aclaris’ 1st transaction in Missouri.

M&A Deal Summary
Date 2017-08-08
Target Confluence Life Sciences
Sector Life Science
Buyer(s) Aclaris
Deal Type Add-on Acquisition
Deal Value 10M USD

Target

Confluence Life Sciences

Saint Louis, Missouri, United States
website
Confluence Life Sciences, Inc. is a privately held biotechnology company focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological disorders and cancer. Confluence Life Sciences was founded in 2010 and is based in Saint Louis, Missouri.

Search 193,711 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Aclaris

Wayne, Pennsylvania, United States

website

Category Company
Founded 2012
Sector Life Science
Employees57
Revenue 31M USD (2023)
DESCRIPTION

Aclaris is a clinical stage specialty pharmaceutical company focused on identifying, developing and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology. Aclaris was founded in 2012 and is based in Wayne, Pennsylvania.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 2 of 2
State (Missouri) 1 of 1
Country (United States) 2 of 2
Year (2017) 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-28 Vixen Pharmaceuticals

United States

Vixen Pharmaceuticals, Inc. is a clinical stage specialty pharmaceutical company.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2019-10-10 RHOFADE

Malvern, Pennsylvania, United States

RHOFADE cream is a prescription medicine used on the skin (topical) to treat ongoing facial redness due to rosacea in adults.

Sell -
Mergr

Product

Company

Legal